A 2-yr whole-body exposure study was conducted to evaluate the chronic toxicity and possible oncogenicity of 60 Hz (power frequency) magnetic fields in rats. Groups of 100 male and 100 female F344/N rats were exposed continuously to pure, linearly polarized, transient-free 60 Hz magnetic fields at flux densities of 0 Gauss (G) (sham control), 20 milligauss (mG), 2 G, and 10 G; an additional group of 100 male and 100 female F344/N rats received intermittent (1 hr on/1 hr off) exposure to 10 G fields. Mortality patterns, body weight gains throughout the study, and the total incidence and number of malignant and benign tumors in all groups exposed to magnetic fields were similar to those found in sex-matched sham controls. Statistically significant increases in the combined incidence of C-cell adenomas and carcinomas of the thyroid were seen in male rats chronically exposed to 20 mG and 2 G magnetic fields. These increases were not seen in male rats exposed continuously or intermittently to 10 G fields or in female rats at any magnetic field exposure level. No increases in the incidence of neoplasms, which have been identified in epidemiology studies as possible targets of magnetic field action (leukemia, breast cancer, and brain cancer), were found in any group exposed to magnetic fields. There was a decrease in leukemia in male rats exposed to 10 G intermittent fields. The occurrence of C-cell tumors at the 2 lower field intensities in male rats is interpreted as equivocal evidence of carcinogenicity; data from female rats provides no evidence of carcinogenicity in that sex. These data, when considered as a whole, are interpreted as indicating that chronic exposure to pure linearly polarized 60 Hz magnetic fields has little or no effect on cancer development in the F344/N rat.
INTRODUCTION
Electric and magnetic fields associated with the production, transmission, and use of electricity are ubiquitous in industrialized society. Because electric and magnetic fields are often generated by the same point source, these fields are commonly referred to as electromagnetic fields, or EMFs. Power frequency electric and magnetic fields in residential and occupational environments in the United States are predominantly 60 Hz and are generally of relatively low intensity (in the low milligauss [mG] range). Most residential exposure is to magnetic fields that are less than 2 mG (equal to 0.2 microtesla) in intensity, although some areas in homes may exceed this intensity. Localized magnetic fields generated by some household appliances can exceed several Gauss (G), especially in the area immediately adjacent to the appliance (20) . In some industries, mean workplace magnetic field exposure may exceed 10 mG (51) .
Electric fields are easily shielded by trees, walls, and other objects, whereas magnetic fields usually penetrate nonferrous material. Because magnetic fields are not easily shielded and because they decrease in intensity only with distance, most residential EMF exposure is to magnetic rather than to electric fields. As such, most recent research on EMF health effects has focused on the identification of potential biological effects of exposure to magnetic fields.
In 1988, the Department of Energy (DOE) and the Electric Power Research Institute (EPRI) nominated 60
Hz (power frequency) electric and magnetic fields to the National Institute of Environmental Sciences for consideration for evaluation in the National Toxicology Program (NTP). DOE and EPRI were prompted by the ex-tensive population exposure to power frequency magnetic fields and by a series of epidemiology studies (49, 55) , the results of which suggested a possible association between residential exposure to 60 Hz magnetic fields and the risk of childhood leukemia.
An important limitation of the early epidemiology studies of magnetic fields and cancer was the lack of magnetic field measurements; in these studies, &dquo;wire codes&dquo; were generally used as a surrogate for magnetic fields within the home (3) . Furthermore, the finding of a positive association between residential exposure to magnetic fields and risk of childhood leukemia has not been a consistent outcome: although increased risk has been reported in a number of residential studies, no correlation between magnetic field exposure and the risk of childhood leukemia was found in other early investigations (1, 12, 19, 33) . A study using calculated fields did find an association between higher estimated magnetic field exposure and the incidence of childhood leukemia for single family dwellings but not for children living in apartments (17) . A recent EMF working group noted a possible association between childhood leukemia and magnetic field exposure (41) .
An occupational epidemiology database concerning magnetic fields and cancer has developed side by side with studies of residential EMF exposure. A number of occupations (commonly referred to as &dquo;electrical occu-pations&dquo;) have been identified; workers in these occupations receive above-average exposure to magnetic fields. Several epidemiology studies of these occupational populations have shown positive associations between workplace exposure to magnetic fields and risk of leukemia (16, 22, 35) . However, other epidemiology studies of similar occupational populations have shown negative associations (18, 27, 53) .
Exposure assessments in many occupational epidemiology studies of magnetic fields and cancer have limitations similar to those of wire codes in residential exposures : occupational EMF exposures are often based on job titles or other broad occupational classifications rather than on measured exposures. As such, their value may be limited by exposure misclassification (48) . A high degree of variability in electric and magnetic field exposures has been found in occupational epidemiology studies (14) , and a number of confounders that complicate their interpretation have been identified (4, 23, 34) .
On the basis of the conflicting epidemiology database for magnetic fields and cancer, limitations to exposure classification in existing epidemiology studies, and the possible presence of unidentified confounders in EMF epidemiology studies, in 1992, the NTP initiated a program to evaluate the toxicity and carcinogenicity of 60 Hz magnetic fields in animal-model systems. Carefully controlled experimental studies using well-characterized magnetic field exposures provide the opportunity to evaluate the possible activity of magnetic fields as a risk factor for cancer induction with extensive exposure characterization and in the absence of known confounders.
Since the inception of the NTP EMF program, the epidemiology database for magnetic fields and cancer has continued to expand, and several potentially sensitive tar-gets for magnetic field action have been identified. Most commonly, increased rates of cancer have been associated with magnetic field exposure in childhood and adult leukemias, childhood and adult brain cancers, and breast cancer in both males and females. Several occupational studies have identified increased incidences of leukemia and brain cancer in workers in electrical occupations (47) , while others have found increased incidences of male breast cancer (15) . In contrast, however, other studies have failed to demonstrate elevated risk of brain cancer in individuals receiving high levels of magnetic field exposure in either residential (17, 38, 54) or occupational environments (51) . The largest recent residential study found no association between childhood leukemia rates and homes with wire codes that suggested higher magnetic fields (28) ; similarly, recent occupational studies have generally identified no association between electrical occupations and increased risk of leukemia (48) . Some studies fail to show an association between occupational exposure to magnetic fields and increased breast cancer rates (51) .
In consideration of the intense public concern related to possible health effects of EMF and in light of the lack of conclusive findings from epidemiology studies, a series of toxicology and carcinogenesis studies of 60 Hz magnetic fields has been conducted using rodent-model systems that are used extensively to support risk assessments. We have previously reported the results of subchronic toxicity studies in rats and mice (7) , a developmental toxicology study in rats (44) , and a battery of immunotoxicology studies in mice and rats (26) ; all studies were considered negative for evidence of toxicity. Studies of the influence of magnetic fields on lymphoma induction in 2 strains of transgenic mice were also negative for an effect on lymphoma induction (31) , as were the results of a multigeneration reproductive toxicity evaluation in rats (37, 45) . The subject of this report is a 2-yr carcinogenesis study in F344/N rats.
MATERIALS AND METHODS
Magnetic Field Exposure and Monitoring. Magnetic Field Facility: Magnetic field exposures were conducted in the Illinois Institute of Toxicology (IIT) Research Institute in vivo magnetic field exposure facility, a 21,000 square foot barrier facility organized on an access/return dual corridor system. The facility is located in an area with low ambient magnetic fields, and it contains 5 identical magnetic field exposure rooms, a quarantine room, and dedicated engineering and animal husbandry support facilities. The ambient magnetic field environment (both AC magnetic fields and DC (the earth's static) magnetic fields) has been extensively characterized throughout animal holding areas of the facility. The fields were measured both outside and within the cages during the validation stage of the study. More detailed information concerning the design, construction, and validation of the operation of this exposure facility is published elsewhere (21) . -Each rectangle represents a coil that was energized to create linear magnetic fields. There were 2 linear magnetic fields, 1 between the upper coils and 1 between the lower coils. Racks holding cages were placed in each of 6 bays (numbered in the diagram). Rats and mice were rotated weekly between the upper and lower fields, and racks were rotated weekly between exposure bays. Every 10 wk, the animals were rotated to another room where similar fields were generated. and Management, Inc. (Pittsburgh, PA). The magnetic field exposure system consists of 5 identical field-generating coil sets, one located in each animal exposure room. Each coil set is arranged as a rectangular solenoid, and it generates horizontal, linearly polarized 60 Hz magnetic fields with spatial homogeneity of ± 10% or better ( Fig.  1 ). Field frequency content is nearly pure 60 Hz, with less than 3% total harmonic distortion. When the exposure system is activated or deactivated, field levels are ramped on or off over 7 to 9 cycles (Fig. 2 ) to prevent the induction of high-frequency transients. The linearity, spatial uniformity, and spectral content of experimentally generated magnetic fields were validated by the National Institute of Standards and Technology prior to the start of the study and annually during the in-life phase of chronic studies.
Animals received whole-body exposure to experimentally generated 60 Hz magnetic fields for 18.5 hr per day for 2 yr. The exposure system was deactivated for 5.5 hr each day (from 7:00 to 11:00 am and from 3:00 to 4:30 pm) to permit personnel entry into the facility for the purposes of animal observation and animal husbandry operations. Procedures for housing and observation of sham controls were identical to those used for animals exposed to magnetic fields, with the following exception: coil sets in the room housing sham controls were not energized.
To control for possible positional effects, a regular schedule of animal rotation was performed throughout Fig. 2 , the fields were started at zero crossing (T) and reached 90% of the field intensity in 9 cycles (0), with full field intensity (X) at approximately 18 cycles. This was recorded for a 10 G field, and each unit on the axis represents 13.9 milliseconds. the in-life portion of the study. Animal rotation included (a) rotation of cages from top to bottom within each rack;
(b) rotation of racks from bay to bay within each exposure room; and (c) rotation of experimental groups from room to room within the facility. Each of the 5 animal exposure rooms housed sham controls and each experimental group for a minimum of two 10-wk periods during the study, thereby serving to control for possible room effects and for the known room-to-room variation in the earth's static magnetic fields.
Magnetic Field and Environmental Monitoring: Magnetic field strength and waveform were monitored continuously throughout the study in each animal exposure room; the monitoring system was alarmed to alert project personnel should field strength deviate more than 5°70 from the target or if total harmonic distortion exceeded 3%. During periods when the exposure system was deactivated (continuously in the room housing sham controls and 5.5 hr per day in other exposure rooms), the monitoring system measured background magnetic fields. Static (DC) magnetic fields and ambient 60 Hz magnetic fields in all animal holding areas of the magnetic field exposure facility were extensively characterized prior to the initiation of the study. The results of these measurements are presented in detail elsewhere (21) .
In addition to magnetic field intensity and waveform, computerized monitoring systems continuously measured room temperature, humidity, air flows, light intensity, noise level, and vibration in all animal exposure rooms. Room temperature was maintained in the range of 72 ± 3°F, and relative humidity was maintained in the range of 50 ± 15%. All animal rooms were maintained on a 12-hr light/dark cycle with a minimum of 10 air changes per hour. Operation of the magnetic field exposure system did not produce any external cues (increases in temperature, noise, or vibration) that could be associated with its operation. Selection of Exposure Conditions: After AC magnetic fields were selected for study by the NTP, a draft protocol was circulated to approximately 80 scientists from government, university, and private sectors, scientists who maintain active research programs in electric and magnetic fields. Based on the recommendations of these sci-entists, the American power line frequency (60 Hz) was selected as the most appropriate metric for study. Linearly polarized magnetic fields were chosen for investigation, since power frequency magnetic fields in most residential environments are essentially linearly polarized. Because residential magnetic fields are primarily composed of 60 Hz sine waves and because harmonics and transients are present as minor components, the pure 60 Hz sine wave (without transients or harmonics) was selected as the most relevant magnetic field metric to be studied.
The highest field intensity selected for study was 10 G (equivalent to 10,000 mG). This flux density is 5,000to 10,000-fold greater than fields present in most residential environments and was considered to reflect a reasonable high-intensity field that can be generated without possible confounding by concomitant production of extraneous cues (sound, vibration, and/or local heating). We have previously reported that subchronic exposure to 10 G fields does not induce significant toxicity in either F344 rats or B6C3F1 mice (7) . The lowest field strength selected for investigation, 20 mG, provides a multiple of 10to 20-fold above normal residential exposures; magnetic fields of this intensity have been measured in certain occupational environments. An intermediate field strength (2 G) was also selected for evaluation, as was a 10 G exposure using a 1 hr on/I hr off regimen. The intermittent exposure regimen at 10 G was designed to investigate the hypothesis that changes in field intensity rather than absolute field strength may be a critical exposure metric in magnetic field bioeffects.
Animals and Animal Husbandry. Male and female F344/N rats were obtained from NTP colonies at Taconic Farms (Germantown, NY) and were quarantined for a minimum of 10 days prior to the initiation of exposures.
Rats were randomized into groups of 100 males and 100 females using a constrained randomization procedure that blocks for body weight. Rats were housed 5 per cage in polycarbonate cages on certified hardwood bedding (Beta-Chips, Northeastern Products, Warrensburg, NY) and were allowed free access to NTP 2000 rodent diet (Zeigler Bros., Gardners, PA) and to City of Chicago drinking water (via automatic watering system). All rats were observed twice daily and were weighed weekly for the first 12 wk of exposure, monthly until week 93, and then every 2 wk until the end of the study. Cages were changed twice weekly. Necropsy and Histologic Evaluation. A complete necropsy with tissue collection was performed on all rats. Tissues were excised, fixed in 10% neutral-buffered formalin, embedded in paraffin, cut, stained with hematoxylin and eosin, and evaluated using methods defined in NTP pathology specifications. All gross lesions and approximately 45 additional tissues from all animals in all study groups were examined histopathologically. All tumors diagnosed in the study were reviewed by a quality assurance pathologist. In addition, because of the interest in the possible effects of magnetic fields on the induction of leukemia, breast cancer, and brain cancer, the spleen and liver, mammary gland, and brain of all animals were also reviewed by a quality assurance pathologist. After survival differences between the magnetic field-exposed and control groups. completion of these evaluations, a pathology working group, consisting of additional pathologists experienced in rodent tissue evaluation, the study pathologist, and the reviewing pathologists reviewed lesions from tissues of interest and from any tissues where a discrepancy existed between diagnoses made by the study pathologist and the reviewing pathologists. Diagnoses were changed only when the opinion of a clear majority of the pathology working group differed from that of the study pathologist. As such, histopathologic diagnoses represent the integration of diagnoses of the study pathologist, the reviewing pathologists, and pathologists participating in the working group. This process has been described previously (10) .
Statistical Methods. Statistical analyses for possible dose-related effects on animal survival were performed using Cox's method for testing 2 groups for equality (13) and Tarone's life table test to identify dose-related trends (50) . The Poly-k test (39, 40) was used to identify differences in the prevalence of neoplasms and nonneoplastic lesions among experimental groups. This is a survivaladjusted quantal-response test in which the Cochran-Armitage trend test has been modified to include differences in survival. Tests of significance included pairwise comparisons of each exposed group with sham controls as well as a test for overall exposure-related trend. A significance level of p < 0.05 was used for all comparisons.
RESULTS

Influence of Magnetic Fields on Survival, Body Weight, and Gross Toxicity
When compared to sex-matched controls, no statistically significant differences in any survival endpoint were seen in any group of rats exposed to magnetic fields (Figs. 3 and 4) . In female rats, survival at 2 yr ranged from 58 to 68% in exposed groups; survival in the female sham control group was 59%. In male rats, survival in groups exposed to magnetic fields ranged from 46 to 59% versus 57% in sham controls. Mean survival time in male survival differences between the magnetic field-exposed and control groups. rats in the sham control group was 692 -!-77 days. By comparison, mean survival time in groups of male rats exposed to magnetic fields ranged from 675 ± 91 days to 688 ± 80 days, or from 97.5 to 99.4% of sham control values. Similarly, mean survival time in female rats in the sham control group was 692 -!-71 days as compared with mean survival times ranging from 684 ±88 days to 705 ± 60 days in groups receiving chronic exposure to magnetic fields. Group mean survival times in female rats exposed to magnetic fields ranged from 98.8 to 101.9% of sham control values. None of these differences in survival was significant at the 5% level.
Chronic exposure to magnetic fields also had no statistically significant effect on body weight in either sex of F344 rats. Within a sex, body weight curves for all experimental groups were essentially superimposable throughout the study (Figs. 5 and 6) . At the final scheduled in-life weighing on day 729 of exposure, mean body weight in male rats in groups exposed to 60 Hz magnetic fields ranged from 96.4 to 98.7% of the sham control mean body weight of 484 ± 62 g. Exposure to magnetic fields did not affect group mean body weight in female rats: at the final in-life weighing, mean body weights in groups of female rats exposed to magnetic fields ranged from 99.6 to 104.0% of the mean body weight of 326 ± 32 g measured in female sham controls.
At no time during the study was any pattern of exposure-related toxicity identified through clinical observation.
Gross Pathology in Rats Exposed to 60 Hz Magnetic Fields Gross pathology of intercurrent deaths and of animals necropsied at the termination of the study provided no evidence of exposure-related effects in any group. A broad spectrum of neoplastic and nonneoplastic lesions was identified in both species. However, the gross pathology findings in both sexes were consistent with the expected pattern of age-related changes in these species and strains and provided no evidence of an effect related to magnetic field exposure.
Microscopic Pathology in Rats Exposed to .
Magnetic Fields
Total Tumor Incidence Patterns in Rats Exposed to Magnetic Fields. Histopathologic evaluation of tissues from rats exposed to 60 Hz magnetic fields revealed no unusual tumor types; both benign and malignant lesions in all groups in the study were generally similar to those reflected in the historical data for F344 rats. No differences in tumor morphology were identified in either sex of animals in the sham control and magnetic field-exposed groups. Comparisons of the total incidence and number of malignant neoplasms, the total incidence and number of benign neoplasms, the total incidence and number of all primary neoplasms combined, and the total FIG. 6.-Body weight curves for the male F344/N rats. There were no body weight differences between the exposure groups and the control groups. incidence and number of metastatic neoplasms provided no evidence that chronic exposure to 60 Hz magnetic fields is a significant risk factor for neoplastic development in F344 rats.
Histologically confirmed metastatic lesions were relatively uncommon in the study, as they occurred in fewer than 5% of animals in all dose groups. In female sham controls, a 3% incidence of metastatic neoplasms was observed, compared with incidences ranging from 1 to 3% in groups of female rats exposed to magnetic fields.
In male rats, 1 % of sham control animals demonstrated metastatic malignancies, compared with 2 to 5 % of animals in groups exposed to magnetic fields. None of these differences was statistically significant.
Leukemia, Brain Cancer, and Mammary Cancer in Rats Exposed to 60 Hz Magnetic Fields. Epidemiologic studies have identified the hematopoietic system, the brain, and the breast as possible target tissues for the oncogenicity of power frequency magnetic fields. The influences of magnetic field exposure on the incidence of benign and malignant neoplasms in these sites and on the incidence of neoplasia in other tissues are discussed separately. Influence of Magnetic Field Exposure on Leukemia Incidence. In view of the existing epidemiologic database, which suggests a possible relationship between exposure to power frequency magnetic fields and risk of childhood leukemia, an important goal of the present study was to determine if chronic exposure to magnetic fields was associated with increases in leukemia incidence in rats. As indicated in Table I , magnetic field exposure did not increase leukemia incidence in any group exposed to magnetic fields. In fact, the only statistically significant difference (compared with sham controls) was a decreased incidence of leukemia (lymphocytic, monocytic, mononuclear, or undifferentiated) in male rats exposed intermittently to 10 G fields (Tables I and II ). The incidence of leukemia in the 10 G intermittent group was 36%, compared with an incidence of 50% in sham controls (p 0.05 by poly-3 test). This decrease in leukemia incidence was not seen in any other group of male rats ex-TABLE II.-Incidence of leukemia, mammary gland, and brain neoplasms in female F344/N rats.
Abbreviation: I = intermittent exposure ( hr on followed by 1 hr off throughout 18.5-hr exposure period).° n = 100 per group. posed to magnetic fields or in any group of female rats receiving magnetic field exposure.
Influence of Magnetic Field Exposure on Brain Cancer Incidence. On the basis of the results of epidemiology studies, the brain has also been identified as a possible target for the oncogenic activity of power frequency magnetic fields. Brain tumors were observed relatively infrequently in the present study but provided no evidence of magnetic field oncogenicity. In male rats in the sham control group, a total of 2 brain tumors (including 1 malignant astrocytoma) were identified. No brain tumors were found in male rats exposed continuously to 20 mG, 2 G, or 10 G fields, and 1 brain tumor was identified in male rats in the 10 G intermittent group. Similarly, a total of 2 brain tumors (including 1 malignant astrocytoma) was found in female rats in the sham control group. By comparison, no brain tumors were found in female rats exposed continuously to 20 mG or 2 G fields or intermittently to 10 G fields; 2 brain tumors (malignant astrocytomas) were identified in the 10 G continuous group. On this basis, the present study did not demonstrate any significant increases in brain tumor incidence in rats exposed to magnetic fields.
Influence of Magnetic Field Exposure on Mammary Tumor Incidence. The third tissue that has been identified through epidemiology studies as a possible target for magnetic field oncogenicity is the breast; these studies have suggested a positive association between magnetic field exposure and human breast cancer in both sexes.
The results of the present study failed to support this proposed association. As expected, the total incidence of mammary gland tumors in male rats in the present study was low: a single mammary cancer was seen in 1 male rat in the 20 mG group, and no mammary carcinomas were seen in male sham controls or in groups of male rats exposed continuously to 2 G or 10 G fields or intermittently to 10 G fields. The incidence of benign mammary tumors (adenomas, fibroadenomas, fibromas) was 6% in male rats in the sham control group and ranged from 6 to 11% in groups of males exposed to magnetic fields. None of these differences was statistically significant. The total incidence of mammary gland tumors in female rats in the present study was similar to that of historical controls. Two female rats in the sham controls developed mammary carcinomas; the incidence of mam -FIG. 7. -Thyroid C-cell hyperplasia in a male F344/N rat exposed to 2 mG magnetic fields. The C-cells are filling contiguous fields, but there is no compression of adjacent thyroid follicles (arrows). X320 .   FIG. 8. -Thyroid C-cell adenoma in a male F344/N rat exposed to 2 mG magnetic fields. The C-cells are filling contiguous fields and show an area of more solid growth (arrows). X 160. mary cancer in exposed female rats ranged from 2 to 7%. The incidence of benign mammary tumors (adenomas, fibroadenomas) was 56% in female rats in the sham control group and ranged from 52 to 64% in groups of females exposed to magnetic fields. None of these differences was statistically significant.
Influence of Magnetic Field Exposure on Tumorigenesis at Other Sites. A statistically significant (p < 0.05) increase was seen in the incidence of thyroid C-cell adenomas in male rats in groups exposed to magnetic field strengths of 20 mG and 2 G; this increase was not seen in groups exposed continuously or intermittently to 10 G magnetic fields (Table III ). An increased incidence of Ccell carcinomas was also seen in male rats exposed to 20 mG fields; this increase was not seen in groups exposed continuously to 2 G or 10 G fields or intermittently to 10 G fields. C-cell hyperplasia was most common in the sham control group, with lower incidence in the 20 mG, 2 G, and 10 G exposure groups.
As diagnosed, C-cell hyperplasia varied from focal to diffuse, with the focal proliferative lesions being smaller than 5 follicles in diameter (Fig. 7 ). C-cell adenomas identified in this study were generally small (Fig. 8) ; however, a few C-cell adenomas filled nearly an entire lobe and were occasionally bilateral. C-cell carcinomas consisted of solid to irregular groups of neoplastic cells FIG. 9. -Thyroid C-cell carcinoma in a male F344/N rat exposed to 2 mG magnetic fields. The C-cells are replacing much of the thyroid (arrows). Not visible at this magnification is the invasion of the thyroid capsule by the C-cells. Uninvolved thyroid follicles, F; Trachea, T X32. that resembled cells found in the C-cell adenoma; larger C-cell carcinomas generally demonstrated more cellular atypia. C-cell carcinomas usually involved the entire lobe of the thyroid (Fig. 9 ) and often invaded the thyroid capsule ; a lung metastasis was observed in 1 case. A variable number of recuts had been made on the thyroid sections to include the parathyroids or for more complete thyroid sections. To remove possible sectioning bias, recuts were made for all male rats to generate 2 sections of all thyroids. The results in Table III represent the evaluation of 2 sections of thyroid per animal.
An increased incidence of preputial gland carcinomas was seen in male rats exposed to 2 G fields (Table IV) ; however, the combined incidence of preputial gland adenomas plus carcinomas was not increased. Although an increase was seen in the incidence of trichoepitheliomas in male rats in the 10 G continuous-exposure group, the overall incidence of epithelial skin tumors was not significantly increased (Table IV) . The incidence of adrenal cortical adenomas was significantly decreased in female rats exposed intermittently to 10 G magnetic fields (Table V) .
DISCUSSION
The primary goal of these studies was to determine whether chronic exposure to 60 Hz magnetic fields alters the incidence or pattern of tumors that occur with aging in the F344 rat. Leukemia, breast cancer, and brain cancer were of primary interest, in view of the reported associations between magnetic field exposure and these tumor types, which have been reported in a number of epidemiology studies. It is important to note, however, that the results of other epidemiology studies of the same disease types have found no relationship with magnetic field exposure (36) . On this basis, the epidemiology data can be considered to be no more than suggestive, and this data clearly does not provide for any conclusive data set upon which risk assessments for magnetic field exposure can be based.
A primary limitation of epidemiology studies in bioelectromagnetics is exposure assessment. Although magnetic fields can be quantitated in both residential and occupational environments, residential and occupational magnetic fields demonstrate significant temporal and spatial variability. As a result, reconstruction of magnetic field exposures presents a major challenge to the epidemiologist ; although a number of approaches have been used to estimate magnetic field exposures, controversy remains as to the relative merits of these different approaches for exposure assessment.
In contrast to the limitations in magnetic field exposure assessment that characterize epidemiology studies in the field, animal studies offer the opportunity to evaluate the biological activity of magnetic fields under carefully controlled exposure conditions and without potential confounding variables. The magnetic field environment to which animals were exposed in the present study can be reconstructed from field strength and waveform data collected at 30-sec intervals throughout the entire 2-yr exposure period. The animal room environment was also carefully controlled; environmental controls were designed to eliminate possible confounders from the study design.
In the present study, chronic exposure to magnetic fields had no effect on mortality patterns or animal body weight; no evidence of exposure-associated toxicity was identified through a regular schedule of clinical observation. Magnetic field exposure had no influence on the total incidence or number of primary malignant tumors or benign tumors and did not alter the total incidence of metastatic lesions. Of particular interest was the finding that magnetic field exposure did not increase cancer incidence in the hematopoietic system, brain, or mammary gland; although the F344 rats do not demonstrate a high incidence of spontaneous brain or breast tumors, these data do not support the hypothesis that magnetic field exposure is increased with increased risk of neoplasia in these target tissues.
An important consideration in the interpretation of negative bioassay data is the statistical power of the test system; statistical power is determined both by group size and by the background incidence of the lesions of primary interest. Assuming leukemia incidences of 50% in male F344 rats and of 20% in female F344 rats, the power of the present bioassay to detect increases of 5, 10, and 20% in the incidence of leukemia was 14, 36, and 87% in males and 17, 44, and 91°lo in females.
Brain malignancies are far less common than are leukemias in F344 rats. Assuming a brain tumor incidence of 2% in both sexes of sham controls, the study design had a 37% power to detect a 5% increase in tumor incidence, a power of 84% to detect a 10% increase in brain tumor incidence, and a power of >99% to detect an increase of 20% in brain tumor incidence. The incidence of mammary cancers in male F344 rats is nearly zero. The study design had a 56% power to detect an increase in mammary cancer incidence from 0 to 5% in male rats, a 98% power to detect an increase in mammary cancer incidence from 0 to 10% in male rats, and a power of >99% to detect an increase in male mammary cancer incidence to 20%. The incidence of mammary tumors in female F344 rats is approximately 5% for malignant lesions, 50% for benign lesions, and 50% for total mammary tumors. Statistical power calculations for malignant mammary tumors in female F344 rats are similar to those provided for brain cancer. The statistical power of the design to detect increases in the incidence of benign mammary tumors or total mammary tumors in female rats (assumed background incidence of 50%) are comparable to that described for leukemia in male rats.
An unexpected finding was the increased incidence of thyroid C-cell adenomas and carcinomas in male rats exposed chronically to the 2 lowest magnetic field strengths studied (20 mG and 2 G). By contrast, no significant increases were seen in male rats exposed continuously or intermittently to 10 G fields or in female rats exposed to any field strength. The observation of increased C-cell tumors was unexpected in that no studies in the epidemiology literature have identified the thyroid as a possible target for magnetic field action (46, 51) . Although Ccells are sensitive to calcium levels (5, 8) , modest changes in intracellular calcium have not been shown to alter C-cell tumor rates in animals (29) . Although relevant experimental data are very limited, we have found that subchronic exposure to magnetic fields has no effect on serum calcium levels in male F344 rats (McCormick and Cahill, unpublished observations).
As rats age, pale staining C-cells increase in number; C-cells may be distributed diffusely throughout the thyroid gland but often demonstrate focal proliferations that may distort and eventually fill the thyroid follicle (9, 11) . Since essentially all aged rats demonstrate some increase in C-cell number, C-cell hyperplasia is diagnosed when this increase becomes a prominent feature in the thyroid gland. Focal C-cell hyperplasia is difficult to distinguish from C-cell adenoma (6) . Since the lesion can progress from diffuse or focal hyperplasia to obvious neoplasia, the criteria used to separate hyperplasia from adenoma are subjective. Cellular atypia, which can be used to distinguish C-cell hyperplasia from C-cell adenoma, was not usually seen in the present study. To ensure diagnostic consistency, both the study pathologist and a reviewing pathologist evaluated all proliferative C-cell lesions prior to assembly of the pathology working group.
As a result of their microscopic nature, C-cell hyperplasia and C-cell adenoma may be present in one histological section of thyroid and absent in a second section taken from the same gland. For this reason, a series of recuts was made to ensure that 2 sections of thyroid from each male rat were evaluated microscopically. By contrast, C-cell carcinomas usually involved the entire lobe of the thyroid gland and generally appeared on both histologic sections.
The observed increase in the incidence of C-cell adenomas and C-cell carcinomas in male rats exposed chronically to 20 mG or 2 G magnetic fields is considered an equivocal finding for several reasons. First, the increase in C-cell neoplasms is not related to field intensity: the highest incidence of C-cell tumors was seen at the lowest field intensity, while no significant increases were seen in animals exposed to the highest field strengths. Second, there is no supporting evidence from preneoplastic lesions. As a general rule, agents that cause neoplasia also increase the incidence of preneoplastic lesions (in this case, C-cell hyperplasia). In the present study, however, the highest incidence of C-cell hyperplasia was found in sham controls (33 of 99 versus 23 of 100 in the 0.02 G exposure group and 27 of 100 in the 2 G exposure groups). C-cell adenomas do not differ morphologically from hyperplasia, except in terms of size (8, 11) , and the combined incidence of C-cell adenomas plus hyperplasias does not differ between groups. On the other hand, more C-cell adenomas were bilateral in the exposed animals than in the controls (zero in controls versus 2 at 20 mG and 4 at 2 G).
Historical control data demonstrate that the incidence of thyroid C-cell tumors is quite variable. In 27 recent NTP chronic studies that used dietary exposure to test articles, the combined rates of C-cell adenoma plus carcinoma in control groups varied from 4 to 35%. Similarly, in 18 recent NTP inhalation studies, the combined rates of C-cell adenoma plus carcinoma varied from 4 to 26% (2). Unfortunately, the incidence of C-cell tumors in the present study cannot be directly compared to historical control rates, because rats in the magnetic field study were fed NTP 2000 rodent diet (42, 43) , whereas animals in historical studies were fed the NIH-07 rodent diet. It has also been demonstrated that identified incidences of C-cell adenomas are subject to variability in sampling techniques: in a comparison study, an 8% incidence of C-cell lesions was identified through evaluations of a single thyroid section, whereas the incidence of C-cell lesions rose to 33% when serial sections were evaluated (52) . In the present study, 2 sections were taken of all thyroids from male rats, whereas only a single section was generally evaluated in the previous NTP studies analyzed.
An unlikely source of variability between groups is diagnostic differences. C-cell lesions represent a spectrum from small focal increases in C-cells to clusters of cells filling thyroid follicles and eventually spreading outside of the thyroid. Small focal lesions are diagnosed as C-cell hyperplasia, whereas larger lesions are diagnosed as C-cell adenoma or, when invasive, as C-cell carcinoma (24) . Thus, moderate differences in diagnostic criteria can lead to different incidence rates in various studies and exposure groups. To control for possible diagnostic differences in this study, the reviewing pathologist evaluated all thyroids for the presence of proliferative lesions. Di-agnostic differences with the study pathologists were resolved by a pathology working group. This procedure reduces diagnostic inconsistencies and should minimize diagnostic differences as a possible source of variability between groups.
In an evaluation of 194 NTP 2-yr studies in male F344 rats, Haseman and Elwell (25) identified only 1 chemical (ziram) that produced an exposure-related increase in the incidence of thyroid gland C-cell tumors. On this basis, the thyroid gland C-cell appears to be a relatively insensitive site for tumor induction. This factor, when considered together with (a) the lack of dose-response relationship for magnetic fields and C-cell tumors in male rats in the present study; (b) the lack of an increase in the incidence of preneoplastic lesions in C-cells in male rats in the present study; (c) the lack of a relationship between C-cell tumors and magnetic field exposure in female rats in the present study; (d) the lack of a relationship between C-cell tumors and magnetic field exposure in other chronic studies of power frequency magnetic field exposure in F344 rats (30, 56) and B6C3F, mice (32) (companion paper to this manuscript); and (e) the lack of a correlate from epidemiological studies of magnetic fields and cancer, it appears unlikely that the observed relationship between magnetic fields and C-cell tumors in male rats is causal in nature.
Finally, the present study involved evaluations of more than 40 tissue sites, 2 gender groups, 4 EMF exposure regimens, and 100 animals per group. Under these conditions, statistically significant differences in neoplasm incidence may arise by chance. The thyroid C-cell in male rats was the only tissue site demonstrating statistically significant increases in tumor response in this study; increased incidences of C-cell neoplasms were seen in male rats in groups exposed to magnetic field strengths of 20 mG and 2 G (p < 0.01 for both groups). Using the design of the present studies, the likelihood of finding at least 1 statistically significant (p < 0.01) pairwise increase in neoplasm incidence by chance is approximately 50%. The corresponding likelihood of observing 2 or more exposure groups that show a significant (p < 0.01) increase in tumor incidence at the same site is approximately 10%. These calculations suggest that random variability cannot be unequivocally ruled out as the source of the apparent increase in the incidence of thyroid Ccell tumors observed in the present study.
A recent National Research Council report concluded that &dquo;no conclusive and consistent evidence shows that exposure to residential electric and magnetic fields produce cancer, adverse neurobehavioral effects, or reproductive and developmental effects&dquo; (36) . The National Research Council noted that an association exists between residential wiring configurations and childhood leukemia, but no such relationship has been demonstrated for measured magnetic fields (36) . The picture was further clouded by a recent report that childhood leukemia was not associated with wiring configurations (28) . In the Linet study, however, a small increase in risk for childhood leukemia was seen in residential exposures of about 3 mG (28) . At this stage, many scientists still consider the possible relationship between residential or occupa-tional exposure to magnetic fields and increased risk for cancer to be an unresolved issue. This long-term rat study provides little support for the hypothesis that exposure to power frequency magnetic fields may be associated with increased cancer risk. The results are similar to those of a Canadian study in which exposure of female F344 rats to 60 Hz magnetic field intensities of up to 20 G for 2 yr resulted in no increase in cancer incidence (30) . Similarly, a Japanese study involving exposure of male and female F344 rats to 50 Hz magnetic field strengths of up to 50 G for 2 yr was also negative for any correlation between exposure and cancer incidence (56) .
Long-term animal studies are expensive, time-consuming, and may be relatively insensitive as a mechanism to identify weak carcinogens. However, when considered together, long-term exposure of rodents to power frequency magnetic fields that are 5,000to 10,000-fold (the present study), 10,000to 20,000-fold (30), and 50,000to 100,000-fold (56) higher than field levels that are routinely encountered in residential environments has demonstrated no pattern of increased cancer risk. These data, when considered as a whole, provide little or no evidence that exposure to pure 60 Hz linear magnetic fields at up to 10 G field intensities for up to 2 yr can affect neoplastic development in the F344/N rat.
